Virus Infections in the Nervous System  by Koyuncu, Orkide O. et al.
Cell Host & Microbe
ReviewVirus Infections in the Nervous SystemOrkide O. Koyuncu,1 Ian B. Hogue,1 and Lynn W. Enquist1,*
1Department of Molecular Biology, Princeton University, Princeton, NJ 08544 USA
*Correspondence: lenquist@princeton.edu
http://dx.doi.org/10.1016/j.chom.2013.03.010
Virus infections usually begin in peripheral tissues and can invade the mammalian nervous system (NS),
spreading into the peripheral (PNS) andmore rarely the central (CNS) nervous systems. The CNS is protected
from most virus infections by effective immune responses and multilayer barriers. However, some viruses
enter the NS with high efficiency via the bloodstream or by directly infecting nerves that innervate peripheral
tissues, resulting in debilitating direct and immune-mediated pathology. Most viruses in the NS are opportu-
nistic or accidental pathogens, but a few, most notably the alpha herpesviruses and rabies virus, have
evolved to enter the NS efficiently and exploit neuronal cell biology. Remarkably, the alpha herpesviruses
can establish quiescent infections in the PNS, with rare but often fatal CNS pathology. Here we review
how viruses gain access to and spread in the well-protected CNS, with particular emphasis on alpha herpes-
viruses, which establish and maintain persistent NS infections.Introduction
Most acute and persistent viral infections begin in the periphery,
often at epithelial or endothelial cell surfaces. Infection of cells at
these sites usually induces a tissue-specific antiviral response
that includes both a cell-autonomous response (intrinsic immu-
nity) and paracrine signaling from the infected cell to surrounding
uninfected cells by secreted cytokines (innate immunity). This
local inflammatory response usually contains the infection. After
several days, the adaptive immune response may be activated
and the infection cleared by the action of infection-specific anti-
bodies and T cells (acquired immunity). Viral infections that
escape local control at the site of primary infection can spread
to other tissues, where they can cause more serious problems
due to robust virus replication or overreacting innate immune
response. This latter reaction is sometimes called a ‘‘cytokine
storm’’ because both proinflammatory and anti-inflammatory
cytokines are elevated in the serum leading to vigorous systemic
immune activity (Figure 1). Such a response in the brain is usually
devastating and can lead to meningitis, encephalitis, meningo-
encephalitis, or death.
The capacity to invade the host nervous system (NS) appears
to be a rather poor evolutionary path because of the potentially
damaging and lethal nature of these infections. In most cases,
acute infection of the central nervous system (CNS) has no
apparent selective advantage for the host or the pathogen.
These infections, when they occur, often represent a zoonotic
infection: an incursion of a virus from its natural host into a
‘‘dead-end host,’’ which has little chance to further disseminate
the infection. Zoonotic virus infections are often minimally path-
ogenic in their natural hosts, but they can be highly virulent and
neuroinvasive in nonnatural hosts. The virulence and lethality of
zoonotic infections may result from the cytokine storm evoked
after the primary infection. The 1918 influenza pandemic and
more recent H5N1 (bird flu) outbreak in humans are good exam-
ples of this phenomenon (Teijaro et al., 2011). Patients infected
with H5N1 virus die, not because of robust virus replication,
but because of acute respiratory distress syndrome (ARDS) trig-
gered by the cytokine storm. Fatal infection by rabies virus
(RABV), and the less known but nonetheless devastating infec-tions caused by West Nile virus (WNV) and Nipah virus also
represent zoonotic infections. When these zoonotic RNA viruses
infect fully differentiated neurons (in the brain and spinal cord),
virus clearance by the immune system is a major challenge.
Because CNS neurons in particular are irreplaceable, canonical
T-cell-mediated cytolysis of these infected cells is not a favor-
able strategy. Thus, as understood by animal models, recovery
from viral infection and the clearance of viral RNA require a
slower process involving the actions of virus-specific antibodies
and interferon gamma (IFN-g) secretion from T cells (Griffin and
Metcalf, 2011).
In contrast to the dangerous zoonotic CNS infections
described above, some human-adapted viruses gain access to
the CNS as a result of diminished host defenses that fail to limit
peripheral infections (e.g., Epstein-Barr virus, human cytomega-
lovirus, JC virus). Others are the result of the iatrogenic introduc-
tion of the infection directly into the CNS, bypassing peripheral
barriers (e.g., use of adenovirus or lentivirus vectors, or prions).
Remarkably, many alpha herpesviruses efficiently enter the pe-
ripheral nervous system (PNS) of their natural hosts and establish
a quiescent infection with little or no CNS pathogenesis. Their
initial peripheral infection stimulates a well-controlled intrinsic
and innate immune response, as well as a long-lived adaptive
immune response. The alpha herpesvirus genomes remain
quiescent in PNS neurons for the life of their hosts, only occa-
sionally reactivating to produce virions that can reinfect periph-
eral tissues and spread to other hosts. Perhaps the prosurvival,
cytolysis-resistant nature ofmature neurons facilitates establish-
ment of such persistent and reactivatable infections.
In this review, after providing a general overview on how
viruses gain access to the NS, we will focus on intra- and inter-
neuronal virus trafficking and spread tactics and discuss how
alpha herpesviruses establish persistent infections in the NS.
We will finish by discussing our views on the control of virus
invasion in the NS.
Entering the Nervous System
While the PNS is relatively more accessible to peripheral infec-
tions because nerves are in direct contact with tissues of allCell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc. 379
Figure 1. Immune Control of Viral Infections
Cellular pattern recognition receptors (PRRs)
recognize viral molecules after attachment and
entry. This initial recognition starts a cell-autono-
mous intrinsic defense involving increased syn-
thesis of many antiviral proteins, and several
cytokines, including type I interferons (IFN-a/b). If
intrinsic defenses fail to stop virus replication,
cytokines and infected cell death activate sentinel
cells (e.g., dendritic cells and macrophages),
which produce copious cytokines and present
antigens to trigger T-cell-mediated immunity. The
innate immune response, which is activated
quickly and robustly, also involves the actions of
the complement system, natural killer (NK) cells,
neutrophils, and other granulocytes. Overreaction
of this response causes immunopathology termed
a ‘‘cytokine storm.’’ The adaptive, acquired
immune response is slow, systemic, and pathogen
specific and leads to the induction of immuno-
logical memory. The cell-mediated ‘‘Th1’’
response involves the action of CD4+ T helper
cells and CD8+ cytotoxic T cells (CTLs). CTLs are
important to kill infected cells and to produce type
II interferon (IFN-g) and tumor necrosis factor
(TNF-a). The ‘‘Th2’’ humoral response involves
CD4+ T helper cells and antibody-producing B
cells. Most of the time, the clinical symptoms of
virus infection (e.g., fever, pain, and tissue damage) are caused by the inflammatory action of the innate and adaptive immune systems. Due to their mostly
irreplacable nature, nervous system tissues rely predominantly on the intrinsic and innate immune responses and avoid the extensive inflammation and cytotoxic
effects of the adaptive immune response.
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infection from the blood to the cerebral spinal fluid and CNS cells
is limited by the blood brain barrier (BBB). The BBB is mainly
composed of endothelial cells, pericytes, astrocytes, and the
basement membrane (Figure 2D). Pericytes project finger-like
processes to ensheath the capillary wall and coordinate the neu-
rovascular functions of the BBB. The star shaped astrocytes (i.e.,
astroglia) are the major glial cell type in the CNS. The astrocyte
endfeet projections ensheath the capillary, regulating BBB
homeostasis and blood flow. Brain microvascular endothelial
cells (BMVECs) that line the CNS vasculature are connected by
tight junctions not found in capillaries in other tissues. These
junctions restrict the egress of bacteria, virus particles, and large
protein molecules from the lumen of the blood vessel, while
allowing the transport of metabolites, small hydrophobic pro-
teins, and dissolved gasses in and out of the CNS. The basement
membrane, a thick extracellular matrix, also surrounds these
capillaries, further limiting movement of pathogens. Perivascular
macrophages (i.e., microglia) residing between the endothelial
and glial cells further provide immune surveillance in the CNS
tissue. Virus infections that leave the periphery and find their
way into the PNS or CNS do so either by direct infection of nerve
endings in the tissues or by infecting cells of the circulatory
system that ultimately carry the infection through the BBB into
the CNS (Table 1 and Figure 2).
Direct Infection of Nerve Endings
Invasion of Sensory Nerve Endings. Some viruses can enter the
PNS by binding to receptors on axon termini of sensory and
autonomic neurons, which respectively convey sensory and
visceral information. Most alpha herpesviruses use this route to
enter the PNS and establish a life-long persistent infection (Tira-
bassi et al., 1998) (Figure 2A). Human alpha herpesviruses
include herpes simplex type-1 (HSV-1), HSV-2, and varicella380 Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc.zoster virus (VZV). Well-studied animal alpha herpesviruses
include pseudorabies virus (PRV) and bovine herpes virus
(BHV). The cellular adhesion molecule Nectin-1 is a major
neuronal receptor for these viruses (except for VZV) (Smith,
2012). Alpha herpesvirus particles enter sensory nerve endings
by membrane fusion and engage dynein motors for retrograde
transport to the neuronal cell body (i.e., soma) (Smith, 2012).
The capsids then dock at the nuclear pore, and the viral DNA
is instilled in the nucleus, where an acute or a quiescent, latent
infection is established. These viruses are unique in maintaining
quiescent infections in the PNS neurons of their hosts. This
quiescent state can be reversed by certain stress stimuli, result-
ing in the production of large numbers of progeny in a relatively
short period of time (1–2 days) (Camarena et al., 2010). Despite
the direct synaptic connection of PNS neurons to the CNS,
spread of alpha herpesvirus infection to the CNS is rare, but
debilitating, in natural hosts (Tirabassi et al., 1998). Alpha
herpesvirus trafficking, latency, and reactivation is further
reviewed in the following sections.
Invasion of Motor Neurons at Neuromuscular Junctions.
Neuromuscular junctions (NMJs) are specialized synapses
between muscles and motor neurons that facilitate and control
muscle movement. NMJs can be gateways for many viruses to
spread into the CNS (Figure 2B). Most motor neurons have their
cell bodies in the spinal cord, which, in turn, are in synaptic con-
tact with motor centers in the brain. Poliovirus and RABV infec-
tions spread into the CNS through NMJs. While RABV particles
enter the NMJ directly after a bite from an infected animal, polio-
virus particles reach the NMJ by a more circuitous route (Raca-
niello, 2006). Poliovirus infection begins with the ingestion of
virus particles followed by replication in the intestinal mucosa
and secretion of new virus particles in feces, typically with no
CNS infection. However, about 1%–2% of poliovirus infections
Figure 2. Virus Entry Routes into the CNS
(A) Alpha herpesviruses (e.g., HSV-1, VZV, and PRV) infect pseudounipolar sensory neurons of PNS ganglia. CNS spread is rare and requires anterograde axonal
transport of progeny virions toward the spinal cord.
(B) RABV and poliovirus spread via neuromuscular junctions (NMJs) from muscles into somatic motor neurons in the spinal cord.
(C) Several viruses may infect receptor neurons in the nasal olfactory epithelium. Spread to the CNS requires anterograde axonal transport along the olfactory
nerve into the brain.
(D) Infiltration through the BBB. The BBB is composed of brainmicrovascular endothelium cells (BMVECs) with specialized tight junctions, surrounding basement
membrane, pericytes, astrocytes, and neurons. Infected leukocytes can traverse this barrier carrying virus into the brain parenchyma.
(E) Alternatively, virus particles in the bloodstream can infect BMVECs, compromising the BBB.
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known motor dysfunction poliomyelitis (Racaniello, 2006). The
receptor for poliovirus is an Ig superfamily member called
CD155, which is found on axonal membranes (Ren and Raca-
niello, 1992). Work in transgenic mice expressing human
CD155 has led to a model in which the virus replicates in motor
neurons within the spinal cord and subsequent retrogradespread of progeny virions to motor centers in the brain results
in muscle paralysis (Kuss et al., 2008; Ohka et al., 2012).
RABV, a member of the Rhabdoviridae family, infects many
animals, including bats, skunks, foxes, and dogs, and rhabdovi-
ruses can even infect insects and plants. RABV in animal saliva
spreads between hosts via bites or scratches. Animals infected
with RABV can survive for months and even years secretingCell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc. 381
Table 1. Classification, Properties, and CNS Entry Routes of Viruses that Can Cause Nervous System Infections
Genome Virus Family N/E Specifics Viruses CNS Entry
dsDNA Adenoviridae N MAV-1 BBB and BMVECs
Herpesviridae E alpha herpesvirus HSV-1, HSV-2, VZV, PRV, and BHV sensory nerve endings and ORN
E beta herpesvirus HCMV BBB and BMVECs
E gamma herpesvirus EBV BBB and BMVECs
Polyomaviridae N JCV BBB and BMVECs
dsRNA Reoviridae N mouse model T3a BBB; peripheral nerve?
(+)ssRNA Coronaviridae E mouse model MHVb peripheral nerve and ORN
Flaviviridae E hepacivirus HCVc BBB and BMVECs
E zoonotic WNVc and JEVc peripheral nerve, BBB, ORN, and BMVECs
Picornaviridae N enterovirus poliovirusc and EV71c NMJs and BBB
N mouse model TMEVd BBB
Togaviridae E zoonotic CHIKVc ORN?
E mouse model SINVe ORN
(–)ssRNA Arenaviridae E zoonotic LCMV BBB
Bornaviridae E zoonotic BDV ORN
Bunyaviridae E zoonotic LACV ORN and BBB?
Orthomyxoviridae E zoonotic influenza Ac peripheral nerve and ORN
Paramyxoviridae E morbilivirus MV BBB
E rubulavirus MuV BBB
E henipavirus (zoonotic) HeVc and Nipahc BBB and ORN?
Rhabdoviridae E zoonotic RabV and VSV NMJs and ORN
ssRNA-RT Retroviridae E lentivirus HIVc and HTLV BBB
dsRNA, double-stranded RNA; ssRNA, single-stranded RNA; N, naked; E, enveloped; ORN, olfactory receptor neuron; RT, reverse transcriptase;
MHV, mouse hepatitis virus.
aRichardson-Burns et al. (2002).
bBergmann et al. (2006).
cEmerging virus.
dTsunoda and Fujinami (2010).
eMetcalf and Griffin (2011).
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results in fatal acutemyeloencephalitis unless treatedwith rabies
antiserum. RABV particles enter the axons of motor neurons at
the NMJ by binding to nicotinic acetylcholine receptors (nAchRs)
and neural cell adhesion molecules (NCAMs) (Ugolini, 2011).
Transneuronal spread occurs exclusively between synaptically
connected neurons, and the infection moves unidirectionally
from postsynaptic to presynaptic neurons (retrograde spread).
A unique feature of RABV infection of humans is the relatively
long asymptomatic incubation period after the initial infection,
which can last from weeks to 1 year. This feature provides
valuable time for intervention with antiserum, which blocks
CNS infection. Once rabies infection reaches the CNS, marked
behavioral and neurological symptoms begin, and death almost
always ensues. If the host survives long enough, virus particles
can spread from the CNS to peripheral tissues, particularly to
the salivary glands.
Invasion via the Olfactory Epithelium and Olfactory Neurons.
The olfactory system provides a unique and directly accessible
portal of entry to the CNS from the periphery. The bipolar olfac-
tory receptor neurons have dendrites in the olfactory epithelium
at the roof of the nasal-pharyngeal cavity, where odors are
detected. The CNS literally is one synapse away from the envi-382 Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc.ronment. The olfactory nerve, which belongs to the PNS, inner-
vates the olfactory epithelium and terminates in the olfactory
bulb in the CNS proper (Figure 2C). The olfactory epithelium is
well protected from most common infections by mucus and
the presence of several pathogen recognition receptor systems
(Kalinke et al., 2011). However, in laboratory models, the olfac-
tory portal can be used by some viruses. There is evidence
that HSV-1, vesicular stomatitis virus (VSV), Borna disease virus
(BDV), RABV, influenza A virus, parainfluenza viruses, and prions
can enter CNS through olfactory route (Detje et al., 2009; Mori
et al., 2005).
Some emerging zoonotic infections may also spread to the
CNS by the olfactory pathway. For example, the paramyxovi-
ruses Hendra virus (HeV) and Nipah virus are natural pathogens
of bats. HeV infection of humans causes lethal pneumonia but
also causes encephalitis by unknown mechanisms. In mice,
HeV is able to infect the CNS after intranasal infection via the
olfactory system, which may also be the infection route in
humans (Dups et al., 2012). An alphavirus, Chikungunyavirus
(CHIKV), from the Togaviridae family, is a mosquito-borne path-
ogen causing high fever, joint pain, and skin rash. Although
CHIKV is not considered a neurotropic virus, CHIKV may spread
into the CNS especially in young or elderly patients (Arpino et al.,
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olfactory path (Powers and Logue, 2007). Similarly, La Crosse
virus (LACV), a mosquito-borne bunyavirus, causes rare but
severe meningoencephalitis, particularly in children. How LACV
spreads into the CNS is controversial, but it may occur via
viremia after the initial replication in muscle cells (Johnson,
1983), or the virus may travel from the olfactory epithelium to
the CNS via olfactory neurons (Bennett et al., 2008).
Invasion by Infected Circulating Leukocytes
Some viruses gain access to the NS without infecting neurons.
Instead, these viruses infect leukocytes, which circulate in the
blood, and may infiltrate in the brain parenchyma. This mecha-
nism is known as ‘‘Trojan horse’’ entry since the pathogens are
hidden within these immune defense cells, which are naturally
able to traverse the BBB (McGavern and Kang, 2011)
(Figure 2D). Lentiviruses, including simian immunodeficiency
virus (SIV) and human immunodeficiency virus (HIV), and another
retrovirus, human T cell leukemia virus (HTLV), may access the
CNS by the Trojan horse mechanism after infection of mono-
cytes or macrophages that infiltrate through the BBB (Kaul
et al., 2001). HIV primarily targets CD4+ T lymphocytes, but it
also infects macrophages/microglia, which function as special-
ized phagocytic and antigen-presenting cells in the CNS, and
astrocytes, which express the cell-surface receptor CD4 and
appropriate chemokine coreceptors (Martin et al., 1997;
Schweighardt and Atwood, 2001). Viral envelope glycoproteins
gp120 and gp41 mediate virion attachment to these receptors.
HIV replication is extensively influenced by the immune response
induced by the infection. For instance, cytokines produced dur-
ing infection can either stimulate virus replication or suppress
viral entry and replication, depending on the nature of the
released cytokine and the state of the cell. CNS invasion occurs
when infected memory T cells or infected monocyte/macro-
phage precursors traverse the BBB, which then differentiate
into perivascular microglia. Virus replication in microglia and
the subsequent induction of an inflammatory cytokine response
damages the CNS, causing depression and cognitive disorders.
Notably, 10%–20% of infected patients exhibit HIV-associated
dementia (HAD) (McArthur et al., 1997). HIV infection also has
an effect on the PNS. Between 30%–60%of AIDS patients suffer
from HIV-associated sensory neuropathy characterized by the
degeneration of myelinated and unmyelinated nerve fibers
(Kamerman et al., 2012).
The picornavirus enterovirus 71 (EV71) (Solomon et al., 2010)
and a ubiquitous human polyomavirus, JC virus (JCV) (Boothpur
and Brennan, 2010), can also infiltrate into the CNS by the Trojan
horse mode of entry. In the case of JCV infection, infiltration of
infected B cells into the CNS in immune suppressed patients
can result in the infection of oligodendrocytes (the myelin-
producing cells) and astrocytes, leading to a fatal inflammatory
disease in the brain called progressivemultifocal leukoencephal-
opathy (PML) (Boothpur and Brennan, 2010).
Infection of Brain Microvascular Endothelium
In some instances, virus particles in the circulatory system can
reach and infect BMVECs, a major constituent of the BBB.
RNA viruses such as WNV (Verma et al., 2010), Hepatitis C virus
(HCV) (Fletcher et al., 2012), HTLV-1 (Afonso et al., 2008), and
DNA viruses such as JCV (Chapagain et al., 2007), Epstein-
Barr virus (EBV) (Casiraghi et al., 2011), human cytomegalovirus(HCMV) (Fish et al., 1998), and mouse adenovirus 1 (MAV-1)
(Gralinski et al., 2009) all can infect BMVECs (Figure 2E). Infec-
tion of these cells often leads to the disruption of BBB integrity,
which is accompanied by the uncontrolled migration of immune
cells into the brain parenchyma. Inflammation in the brain tissue
induced by the activity of these cells is usually the cause of the
observed neurological disorders.
WNV, an arthropod-borne flavivirus, causes encephalitis and
meningitis in a small percentage of infected humans after the
initial replication in keratinocytes and Langerhans cells in the
skin (Lim et al., 2011). CNS infections often are associated with
inefficient immune clearance of infection in the peripheral tissues
and the resulting robust virus replication and subsequent viremia
(Cho and Diamond, 2012). WNV can access the CNS either by
infecting sensory nerve endings or olfactory neurons or through
blood circulation, but not via NMJs (Lim et al., 2011). A hallmark
of WNV neuropathogenesis is the disruption of the BBB, result-
ing in uncontrolled entry of immune cells into the brain. The infec-
tion not only stimulates the loss of tight junction proteins in both
epithelial and endothelial cells (Xu et al., 2012), but also induces
production of matrix metalloproteinases that degrade the base-
ment membrane. As a result, leukocytes traverse the capillaries
into surrounding tissue and release cytokines upon recognition
of WNV double-stranded RNA (dsRNA) via toll-like receptor 3
(TLR3) and tumor necrosis factor alpha (TNF-a) signaling (Verma
et al., 2010; Wang et al., 2004). These events are unique to WNV
and are not observedwith other hemorrhagic flaviviruses such as
Dengue virus (Xu et al., 2012). HIV, HTLV-1, and MAV-1 infec-
tions also may disrupt the BBB by affecting tight junction pro-
teins (Afonso et al., 2008; Gralinski et al., 2009). MAV-1 infects
both BMVECs and macrophages, leading to acute encephalo-
myelitis in susceptible mouse strains, which might explain how
human adenovirus infections in immunodeficient patients leads
to encephalitis with mortality rate approaching 60% (Ashley
et al., 2009; Gralinski et al., 2009).
Another flavivirus, HCV, which primarily infects hepatocytes,
has also been associated with CNS abnormalities such as cogni-
tive dysfunction, fatigue, and depression (reviewed in Fletcher
andMcKeating, 2012). BMVECs are the only cell type in the brain
that express all four receptors required for HCV entry (scavenger
receptor BI, CD81, claudin-1, and occludin). They also support
HCV infection in vitro, suggesting that they may be the CNS
reservoir of HCV (Fletcher et al., 2012). CNS infection by HCV
is also associated with increased expression of proinflammatory
cytokines (interleukin-1 [IL-1], TNF-a, IL-12, and IL18), choline,
creatine, and inositol, all of which trigger microglia and astrocyte
activation, leading to pronounced neurological disorders
(Fletcher and McKeating, 2012).
Prevalent human DNA viruses that establish life-long, well-
controlled persistent infections in other tissues can also damage
the CNS by infecting BMVECs under immune-suppressive con-
ditions. The beta herpesvirus HCMV (Fish et al., 1998), the
gamma herpesvirus EBV (Casiraghi et al., 2011), and the polyo-
mavirus JCV (Chapagain et al., 2007) are among such patho-
gens. HCMV establishes life-long latency, predominantly in the
cells of the myeloid lineage (Goodrum et al., 2004). If the primary
infection happens during pregnancy, transmission to the not-
yet-immune-competent fetus may result in a variety of fatal
CNS abnormalities, such as mental retardation and hearingCell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc. 383
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glial cells, and, importantly, neural stem cells all can be infected
with HCMV (Cheeran et al., 2009; Fish et al., 1998). Astrocytes
and microglial cells naturally produce copious quantities of in-
flammatory cytokines in response to HCMV infection, and this
response can promote fetal neurodevelopmental diseases.
EBV establishes life-long latency in memory B cells (Speck
and Ganem, 2010). EBV infection in young adults causes infec-
tious mononucleosis. In rare cases, EBV infection leads to B
cell lymphomas (e.g., Burkitt’s lymphoma) and epithelial cell
carcinomas (e.g., nasopharyngeal carcinoma). Horwitz and col-
leagues showed that EBV can infect human BMVECs, where it
becomes latent (Casiraghi et al., 2011). Virus reactivation in
these cells increases inflammatory cytokine and chemokine
expression, affecting the integrity of the local BBB, which might
lead to progression of the inflammatory neurological disease
multiple sclerosis (MS) (Casiraghi et al., 2011).
Virus Induced Immune-Mediated CNS Pathogenesis
The BBB may be disrupted by mechanisms other than endothe-
lial cell infection. Local production of cytokines in the CNS due to
viral infections affects tight junctions of the BBB as well. For
example, expression of the chemokine monocyte chemoattrac-
tant protein-1 (MCP-1, CCL2), which is induced by viral infec-
tions, is sufficient to disrupt tight junction proteins in the BBB
(Stamatovic et al., 2005) and predispose the brain tissue for
immune-mediated neuropathology. An interesting example of
virus-induced immune-mediated CNS pathogenesis is the rare,
but fatal, Borna disease virus (BDV) infection. BDV, a zoonotic
RNA virus infecting warm-blooded animals, establishes persis-
tent, noncytolytic infection in the CNS, particularly in neurons
of the limbic system (cortex and hippocampus) (Planz et al.,
2009). The transmission route into the CNS is probably via the
olfactory system, followed by axonal transport and transsynaptic
spread to other parts of the brain (Lipkin et al., 2011). Depending
on the immune state of the host, BDV replication interferes with a
multitude of signaling cascades, deranging the expression of
cytokines, neurotrophins that control neuron survival and func-
tion, and apoptosis-related genes, leading to neuropathogene-
sis. Although controversial, human BDV infections might be
associated with a variety of neurological disorders, including
unipolar depression, bipolar disorder, and schizophrenia (Lipkin
et al., 2011).
Lymphocytic choriomeningitis virus (LCMV) is a rodent-borne
human pathogen that causes CNS disease. Pathogenesis
occurs through the combinatorial effects of virus replication
and the subsequent host immune response. Humans acquire
this infection by inhalation of aerosols or dust suspensions. After
the initial replication in lung cells, LCMV virions move into the
circulation and can enter the CNS. In animal models, LCMV
preferentially infects nonneuronal cells in the brain (i.e., glial
cells), which triggers a robust inflammatory response and inter-
feres with neuronal migration (Bonthius, 2012).
Influenza A (i.e., H5N1, H1N1), an orthomyxovirus that is both
zoonotic and endemic in human population, primarily replicates
in the lungs after transmission through the respiratory tract.
Some of the Influenza A isolates (i.e., HK483) are neurovirulent
and can spread to the CNS through olfactory, vagus, trigeminal,
and sympathetic nerves in mouse models (Park et al., 2002).
Interestingly, neurological and cognitive effects associated384 Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc.with influenza infection have also been reported after nonneuro-
tropic H1N1 pandemics. Recent work shows that increased
production of proinflammatory cytokines and activation of
microglia upon peripheral, nonneurotropic influenza (A/PR/8/
34) infection contributes to altered hippocampal structures and
cognitive dysfunction in mice in the absence of neuroinvasion
(Jurgens et al., 2012).
Paramyxoviruses, measles virus (MV), and mumps virus
(MuV), which are the causative agents of highly communicable
diseases, can also lead to serious CNS infections. Primary MV
and MuV infections begin in the upper respiratory tract, and
infection of lymphoid tissue causes viremia and spread to other
tissues. MuV is highly neurotropic and can cause acute enceph-
alopathy in children with high incidence. Elevated levels of
multiple cytokines were detected in cerebrospinal fluids of chil-
dren diagnosed with MuV-associated acute encephalopathy
(Watanabe et al., 2013). Unlike MuV, MV infection spreads to
the CNS in approximately 0.1% of the cases, causing several
types of devastating neurological diseases, such as fatal sub-
acute sclerosing panencephalitis (SSPE), which manifests
weeks to years after infection (reviewed in Buchanan and
Bonthius, 2012). Although the molecular mechanisms of CNS
infection are not well understood, transgenic rodent models
reveal that a complex interplay of innate and adaptive immune
system responses are involved including disrupted Th1/Th2
balance and defective T cell proliferation (Schneider-Schaulies
et al., 2003).
These selected examples of neuropathogenesis caused by
diverse virus families demonstrate that, while virus replication
itself may cause neuropathologies, the activated immune
system also contributes to the neuronal damage in an effort to
eradicate the infection. Moreover, immune-mediated changes
in the CNS induced by one virus infection might stimulate the
neuropathogenicity of other viruses, as is seen in coinfections
with HIV and HCV, JCV, or HCMV. To better comprehend
the effects of viral invasion on the NS, we must understand
how viruses interact with, replicate in, and spread in between
neurons.
Cell Biology of Neuronal Infection and Spread
Neurons are highly polarized, with distinct dendrite and axonal
processes. Single axons can extend meters, many thousands
of times the diameter of a typical cell. The maintenance and
the communication of distal axons with their cell bodies requires
highly specialized signal transduction, intracellular sorting, traf-
ficking, and membrane systems. As obligate intracellular para-
sites, viruses are dependent on these cellular functions that are
often cell-type specific. Accordingly, neurotropic viruses can
be divided into two categories: those that accidentally or oppor-
tunistically spread to the specialized NS (e.g., WNV, HCV, and
EBV) and those that have adapted to the NS (e.g., alpha herpes-
viruses and RABV). From a human health perspective, these
fundamental differences in virus-host interaction result in the
broad range of viral pathogenesis. In this section, we will sum-
marize how viral infections engage neuronal cell biology to enter,
traffic, and spread between neurons.
Entry
In general, virions may enter cells by direct fusion with or pene-
tration of the plasma membrane or by endocytosis. Alpha
Figure 3. Cell Biology of Virus Entry,
Transport, and Spread in the NS
(A) Virons enter axons either via direct fusion
with the axonal membrane after receptor attach-
ment (e.g., alpha herpesviruses) or by endo-
cytosis (e.g., RABV; most neurotropic viruses). All
particles entering the axon cytoplasm require
minus-end-directed dynein motors for long-
distance retrograde transport on microtubules
toward the cell body. Microtubules in axons are
uniformly oriented with plus ends facing the axon
terminus and the minus ends in the cell body. In
the cell body and dendrites, microtubules have
mixed polarity.
(B) Postreplication trafficking and spread of
progeny virions. Progeny alpha herpesvirus virions
in transport vesicles can be transported antero-
grade in axons, dependent on the viral protein Us9
associating with the microtubule motor kinesin-3/
KIF1A. Egress from axons allows anterograde
virus spread from presynaptic to postsynaptic
neurons. Virions in transport vesicles can also
traffic to and egress from the somatodendritic
compartment, allowing retrograde spread from
postsynaptic to presynaptic neurons. Accordingly,
herpesviruses can spread bidirectionally in neu-
ronal circuits. In contrast, enveloped RNA virions
(e.g., RABV and MV) acquire their membranes by
budding though the plasma membrane during
egress. For these viruses, the location of envel-
opment/egress and the directionality of spread
may depend on the transport and intracellular
localization of viral glycoproteins. These viruses
tend to spread unidirectionally, only from post-
synaptic to presynaptic neurons.
Cell Host & Microbe
Reviewherpesviruses enter neurons by direct fusion of their virion
envelopes with the plasma membrane (Figure 3A) (Lycke
et al., 1988). Nectin-1, a member of the immunoglobulin (Ig)
superfamily, is a receptor for HSV and PRV virions and engages
the conserved viral glycoprotein gD on the virion surface to
initiate the entry process. After membrane fusion, the capsid
with inner tegument proteins is deposited into the axonal
cytoplasm, ready for subsequent intracellular transport steps
(Smith, 2012).
Most other neurotropic viruses enter neurons by endocytosis,
using cellular receptors that are concentrated at nerve terminals
(Figure 3A). The following neuromuscular junction proteins
serve as viral receptors: NCAMs and nAChRs for RABV (Ugolini,
2011), CD155 for poliovirus (Ohka et al., 2004), and the coxsack-
ievirus and adenovirus receptor (CAR) (Salinas et al., 2009). In
addition, many viruses that do not infect neurons during natural
infections can enter nerve terminals by endocytosis when
artificially introduced, for example, during experimental or iatro-
genic infections with adenovirus (Salinas et al., 2009), adeno-
associated virus (AAV) (Cearley and Wolfe, 2007), and lentivirus
vectors (Mazarakis et al., 2001).
The molecular mechanisms of endocytosis are well studied
in a variety of cell types (Mercer et al., 2010). Compared to
nonneuronal cells, neuronal endocytosis is highly regulated,Cell Host & Microbeand it is mediated by many neuron-
specific isoforms of the conserved
endocytosis machinery. At nerve termi-
nals, in particular, the most prominent
and best studied endocytic activity is aspecialized mode of clathrin-mediated endocytosis for neuro-
transmitter reuptake and synaptic vesicle recycling (Saheki
and De Camilli, 2012). These endocytosis-derived recycled
synaptic vesicles typically remain near the presynaptic active
zone for ongoing rounds of endo- and exocytosis, and
therefore their role in mediating viral entry is unclear. Other
vesicle populations, including those with canonical early and
late endosomal markers like Rab5 and Rab7 GTPases, are
present in axons, but their genesis, fate, and role in virus entry
is also uncertain.
Upon endocytosis, the lumen of endocytic vesicles is rapidly
acidified by vacuolar ATPases. In nonneuronal cell types, this
pH change is often a trigger for virions to fuse with or otherwise
disrupt the vesicle membrane to reach the cytoplasm (Mercer
et al., 2010). Interestingly, in neurons, most virions remain inside
the endocytic vesicle for subsequent long-distance retrograde
trafficking to the neuronal cell body (e.g., rabies virus [Klingen
et al., 2008], polio [Ohka et al., 2009], and adenoviruses
[Salinas et al., 2009]). Studies of the endocytosis and trafficking
of canine adenovirus 2 (CAV-2) and tetanus neurotoxin (TeNT)
revealed a population of endocytic vesicles with a neutral
pH, suggesting that such nonacidified vesicles may generally
promote the retention and subsequent trafficking of neurotropic
viruses (Salinas et al., 2010).13, April 17, 2013 ª2013 Elsevier Inc. 385
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After axonal entry, virus particlesmust undergo retrograde trans-
port to the cell body usingmotor proteins that move alongmicro-
tubules (Figure 3A). Generally, in polarized cells and particularly
in axons, microtubules are oriented with the plus end at the cell
periphery or axon terminal and the minus end toward the cell
body. The kinesin family of motor proteins generally mediates
plus-end-directed anterograde transport (from the soma to the
axon terminus), and dynein motor complexes generally mediate
minus-end-directed retrograde transport (from axon terminus to
soma) (Kapitein and Hoogenraad, 2011).
After membrane fusion and entry into axons, alpha herpes-
virus capsid-inner tegument complexes undergo very efficient
retrograde transport to the cell body (Figure 3A). The viral pro-
tein VP1/2 (UL36), a major component of the inner tegument,
recruits minus-end-directed dynein motors for this retrograde
transport (Zaichick et al., 2013). However, retrograde axonal
transport is punctuated by brief anterograde movements, puri-
fied capsid/inner tegument complexes also bind kinesin motors,
and VP1/2 is a multifunctional protein involved in multiple intra-
cellular transport steps during virus replication (Smith, 2012).
Thus, motor recruitment by VP1/2, and other viral and cellular
factors, is likely a complex and regulated process requiring
further study.
Like alpha herpesvirus particles, RABV virions were thought to
immediately undergomembrane fusion, releasing the viral nucle-
ocapsid into the axon cytoplasm, as typically occurs in non-
neuronal cell types. The nucleocapsid-associated P protein
was proposed tomediate retrograde axonal transport by binding
dynein light chain LC8. However, other studies demonstrated
that P protein binding to LC8 is not necessary for RABV neuropa-
thogenesis (Mebatsion, 2001), and RABV virions instead remain
within endocytic vesicles during retrograde transport (Klingen
et al., 2008) (Figure 3A).
The fact that most neurotropic viruses, particularly those not
adapted to the nervous system, are transported within endocytic
vesicles presents an inherent topological problem. Unlike alpha
herpesvirus particles, which are exposed to the axon cytoplasm
immediately after entry, these endocytosed virions are trapped
in the lumen of an endosome and therefore can neither recruit
motor complexes nor directly modulate the transport machinery,
but may remain passive cargo of the pre-existing axonal
transport pathways. Several viruses appear to use a common
retrograde transport pathway involved in neurotrophin signal
transduction. In this signaling pathway, neurotrophins (e.g.,
nerve growth factor [NGF] and brain-derived neurotrophic factor)
and their receptors (e.g., p75NTR and TrkB) are incorporated
into Rab5-positive early-endosome-like vesicles, which mature
into Rab7-postive late-endosome-like vesicles. Rab7 mediates
recruitment of dynactin (p50/glued), part of the dynein complex,
and these vesicles undergo retrograde transport to the neuronal
cell body (Deinhardt et al., 2006). This pathway is implicated in
the retrograde transport of poliovirus (Ohka et al., 2009), rabies
virus (Langevin et al., 2002), CAV-2, and TeNT (Salinas et al.,
2009, 2010). These endosomal transport vesicles appear to
remain at a neutral pH, which may stabilize pH-dependent
viruses within the endosome (Salinas et al., 2009, 2010).
In some cases, the interaction between virions and their
cellular receptors may direct the retrograde transport of the386 Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc.virion-containing endocytic vesicle. For example, the poliovirus
cellular receptor CD155, which is endocytosed along with the
virion, binds the dynein light chain Tctex-1 to engage the retro-
grade transport machinery (Ohka et al., 2004). Similarly, the
envelope glycoprotein (G protein) of RABV and related rhabdovi-
ruses can confer endocytosis and efficient retrograde transport
functions to heterologous lentivirus vector particles (Desmaris
et al., 2001; Mazarakis et al., 2001), suggesting that interaction
between the G protein and a cellular receptor (possibly
p75NTR [Langevin et al., 2002]; see above) mediates retrograde
transport.
While these examples provide some insight into the molecular
mechanisms of postentry retrograde transport, it is not clear
whether virions endocytosed at nerve terminals engage a com-
mon or default retrograde transport pathway and to what extent
they alter or modulate these intracellular traffickingmechanisms.
After entry and retrograde transport to the cell body, viral nu-
cleic acid genomes replicate and express messenger RNA
(mRNA) and proteins. Remarkably, the biosynthetic machinery
(i.e., ribosomes and secretory pathway organelles) of neurons
is distributed in axons and dendrites, as well as in the cell bodies.
It is not clear whether this distribution of cellular machinery
facilitates compartment-specific viral replication and gene
expression.
Postreplication Transport, Egress, and Spread
Many neurotropic virus infections (e.g., RABV, alpha herpesvi-
ruses, MV, and WNV) spread between chains of connected neu-
rons. Virions do not typically spread by free diffusion, but rather
between tightly connected neurons via neurochemical synapses
or other close cell-cell contacts. Infected PNS neurons often are
in direct synaptic contact with CNS neurons, providing a direct
route of spread from the periphery. Consequently, CNS infection
is determined in part by the directionality of virus spread along
neuronal circuits, which is influenced by directional intracellular
virus transport and egress. Motor neurons receive input from
CNS neurons via synapses on the somatodendritic plasma
membrane (i.e., postsynaptic contacts) and relay these signals
to neuromuscular junctions at axon termini. RABV, which
typically infects motor neurons, spreads exclusively in the retro-
grade direction along neuronal circuits, exiting from the somato-
dendritic plasma membrane to spread toward the CNS
(Figure 2B). Most neurotropic viruses are capable of spreading
retrograde in neural circuits, suggesting that there may be com-
mon or default somatodendritic transport pathways. In contrast
to motor neurons, sensory neurons are typically pseudounipolar,
with two axon-like projections: one innervating peripheral
tissues, and the other making presynaptic contact with CNS
neurons (Figure 2A). To be able to spread within this pseudouni-
polar architecture, the alpha herpesviruses have evolved the
capacity to spread in the anterograde direction, exiting from
axon termini. The alpha herpesviruses are among the very few
viruses that are capable of bidirectional spread (both antero-
grade and retrograde direction) (Figure 3B).
Like postentry transport, postreplication transport of viral
components also requires microtubule motors. The cellular
mechanisms that determine whether cargo is transported into
the axon or into dendrites are not entirely clear; however, several
mechanisms are apparent (Kapitein and Hoogenraad, 2011).
First, the axon initial segment contains a mesh of actin filaments
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lecular complexes like transport vesicles or virions from entering
the axon nonspecifically. Some motors, for example kinesin-1/
KIF5, efficiently penetrate this barrier, providing a level of spec-
ificity so that only particular cargo/adaptor/motor combinations
are transported into the axon. Second, stable microtubules
acquire posttranslational modifications, most notably C-terminal
detyrosination and K40 acetylation of alpha-tubulin. Both axons
and dendrites contain acetylated microtubules, and axons are
enriched in detyrosinated microtubules. Kinesin-1/KIF5 prefer-
entially binds thesemodifiedmicrotubules, suggesting that post-
translational modifications may also regulate cargo transport
into axons. Finally, microtubule polarity differs between axons
and dendrites. While microtubules in axons have a uniform, par-
allel orientation, with plus ends at the axon terminus and minus
ends in the soma, microtubules in dendrites havemixed, antipar-
allel orientations. This difference in microtubule polarity would
allow only plus-end-directed kinesin motors to enter axons,
whereas the minus-end-directed dynein complex could enter
dendrites (Kapitein and Hoogenraad, 2011). Indeed, one study
using a drug-inducible protein dimerization system showed
that experimental recruitment of kinesin-1/KIF5 or kinesin-2/
KIF17 induces cargo transport into axons, whereas recruitment
of dynein induces transport into dendrites (Kapitein et al., 2010).
While enveloped virions may exit cells by budding though
cellular membranes, which preserves membrane topology, non-
enveloped viruses (e.g., poliovirus and Ad) must breach mem-
branes to enter or exit a cell. How nonenveloped viruses cross
cellular membranes, particularly neuronal membranes, without
causing extensive cytopathology is not well understood (re-
viewed in Kirkegaard, 2009). However, a study on Theiler’s
murine encephalomyelitis virus (TMEV), a nonenveloped picor-
navirus like poliovirus, revealed that TMEV can exit from neurons
into oligodendrocytemyelin sheathswithout axon lysis or degen-
eration (Roussarie et al., 2007). It is not clear whether other
nonenveloped viruses can spread between neurons without
cell lysis or axon degeneration.
In the case of many enveloped viruses (e.g., RABV and MV),
final assembly and egress are coordinated processes (Fig-
ure 3B). Viral components and subassemblies, such as nucleo-
capsids and membrane proteins, are transported separately
and meet at the plasma membrane. Virions then acquire their
envelope by budding through the plasma membrane, simulta-
neously completing assembly and egress from the cell. For
decades, researchers have recognized that viral membrane pro-
teins (i.e., glycoproteins and matrix proteins) are sorted either to
the apical or basolateral side of polarized epithelial cells and that
release of enveloped viruses is often polarized accordingly (see
Jayakar et al., 2004, for relevant discussion). Analogously, if viral
envelope proteins are preferentially sorted into the axons or den-
drites, virion assembly, egress, and transsynaptic spread may
also be polarized. In support of this model, a recent study
showed that the directionality of viral spread along synaptic con-
nections depends on the viral glycoprotein G (Beier et al., 2011).
In this study, the authors produced recombinant VSV express-
ing G proteins from RABV (a related rhabdovirus), LCMV (an
unrelated arenavirus), or its native VSV G protein. The RABV G
protein conferred retrograde (postsynaptic to pre-synaptic)
spread across synaptic connections, whereas the LCMV ornative VSV G proteins conferred anterograde (presynaptic to
postsynaptic) virus spread (Beier et al., 2011). While it is difficult
to draw conclusions about the functions of viral proteins outside
of their natural context, these studies contribute toward a mech-
anistic understanding of viral spread in the NS. But important
questions remain: What are the molecular determinants of viral
glycoprotein sorting in neurons? How is the transport of nucleo-
capsids and other viral factors coordinated to ensure efficient
assembly and egress? And, does this glycoprotein-centric
model hold true for other enveloped viruses?
The transport of nascent alpha herpesvirus particles is now
understood in more molecular detail. These viruses replicate
their genome and assemble capsids in the nucleus, traverse
the nuclear envelope, acquire tegument proteins, and obtain
their envelope by budding into trans-Golgi-like membranes
(Smith, 2012). There has been some debate as to whether alpha
herpesviruses fully assemble in the neuronal cell body prior to
axonal transport or whether subassemblies are transported to
distant sites of final assembly. The details of this debate are re-
viewed elsewhere (Diefenbach et al., 2008; Smith, 2012), but it is
clear that alpha herpesviruses have evolved neuron-specific viral
mechanisms to direct anterograde transport and spread along
circuits of synaptically connected neurons. For both HSV
and PRV, three conserved viral membrane proteins, gE, gI, and
US9, are necessary for efficient anterograde transport and
spread (Smith, 2012). While the role of US9 in HSV is debated,
US9-null PRV mutants are completely defective in anterograde
transport and spread in neurons, and these phenotypes appear
to be neuron specific (Lyman et al., 2007). US9 is dispensable in
nonneuronal cells and for retrograde somatodendritic egress in
neurons. A recent study demonstrated that PRV US9 associates
with the neuron-specific plus-end-directed microtubule motor
kinesin-3/KIF1A, providing a molecular basis for this neuron-
specific phenotype (Kramer et al., 2012). According to this
model, PRV US9 mediates the recruitment of KIF1A, which me-
diates both sorting into axons and anterograde transport leading
to spread of infection from presynaptic to postsynaptic cells in a
neuronal circuit (Figure 3B). Thus, in bipolar neuronal circuitry,
PRV serves as an illustrative example of how directional spread
along neuronal circuits depends on the directionality of intracel-
lular transport and egress. Ongoing research to identify the
cellular and molecular mechanisms of viral transport and egress
in neurons will be necessary to fully understand how other neuro-
tropic viruses spread through the NS.
However, directional transport in neurons is not the sole deter-
minant of spread in neuronal circuits. For example, PRVandother
alpha herpesviruses naturally infect pseudounipolar sensory
neurons that have two axon-like projections. Thus, anterograde
axonal transport could direct progeny virions downeither branch,
into peripheral tissues or into the CNS (Figure 4). Yet, spread to
the CNS is typically rare or inapparent. In this case, the direction-
ality of spread in thenervoussystemmaydependon factors other
than intracellular transport, such as intrinsic immune responses
and latency, as described in the following section.
Alpha Herpesvirus Invasion of the Nervous System:
The Potential for a Lifetime Association
The life-long persistence of herpesvirus genomes in their natural
hosts coupled with the capacity to reactivate the quiescentCell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc. 387
Figure 4. Establishment and Control of Alpha Herpesvirus Latency in PNS Neurons
HSV-1 enters the host organism through mucosal/epithelial surfaces. Initial replication in epithelial cells results both in cytokine secretion and viral spread.
Progeny virions enter sensory nerve terminals and undergo long-distance retrograde transport to the neuronal cell body. Localized intracellular signaling and
protein translation in distal axons induced by cytokines and viral proteins during entry supports retrograde particle transport and also may influence the
establishment of latency in neuronal cell bodies. Once in the nucleus, viral latency genes are activated (e.g., LAT and miRs), and the HSV-1 genome is repressed.
CD8+CTLs secreting IFN-g and granzyme-B and continuous retrograde NGF-PI3K-mTOR signaling fromdistal axons contribute tomaintaining this latent state of
infection. If this homeostasis is disrupted by environmental or nutritional stress, the HSV-1 genome reactivates lytic gene expression, leading to virus replication.
Newly replicated virions traffic back by anterograde axonal transport mechanisms, to reestablish infection at epithelial tissues. It is still not understood why CNS
invasion is rare after reactivation from latency, even though both axonal projections of the pseudounipolar sensory neuron are accessible to HSV-1 virion
transport. If there is no difference in transport, it may be that HSV-1 does invade the CNS but is strongly suppressed or silenced by an effective intrinsic immune
response in CNS neurons of healthy individuals.
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hosts is remarkable in many ways (reviewed in Wagner and
Bloom, 1997). Three subfamilies of the herpesviridae establish
a latent persistent infection in different cell types: alphaherpes-
virinae (PNS neurons), betaherpesvirinae (monocytes and mac-
rophage precursors), and gammaherpesvirinae (B and T cells)
(Speck and Ganem, 2010). In most cases, the quiescent herpes-
virus genome is not integrated into the host genome and either
exists as a nonreplicating, quiescent histone-covered molecule,
or as a replicating extra ‘‘chromosome’’ (reviewed in Speck and
Ganem, 2010). Recently, this paradigm was broken by human
herpesvirus 6, a beta herpesvirus that can integrate into the
host genome (Arbuckle et al., 2010).
Alpha herpesvirus genomes can remain in a latent, but reacti-
vatable, state in neurons of essentially all PNS ganglia. HSV-1
and HSV-2 are two human alpha herpesviruses causing cold
sores and genital herpes. A third human alpha herpesvirus,
VZV, causes chickenpox during primary infection of children
and zoster (shingles) when the virus reactivates in the ganglia
that transmit sensory signals toward the brain (e.g., dorsal root
ganglion and trigeminal ganglion). Infection initiates in epithelial
cells at a mucosal surface. The primary infection is usually well
contained by host defenses, and overt pathogenic effects are
rare. Some viral progeny invariably enter axon terminals that
innervate the infected tissue and move on microtubules to PNS
cell bodies, where a productive or latent infection may be estab-
lished (Figure 4). Establishment of the quiescent infection in PNS388 Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc.neurons is a multistep process and depends on the efficiency of
several parameters: (1) virus replication in nonneuronal cells un-
der the pressure of local intrinsic, innate, and humoral immune
responses, (2) virion entry into axon terminals and retrograde
transport of nucleocapsids to the neuronal cell body, and (3)
intrinsic and innate immune responses in the infected neuron
and ganglia. After the latent infection is established, mainte-
nance of this silent state requires continuous action of surround-
ing glial and virus-specific CD8+ T cells that suppress lytic gene
expression through secretion of IFN-g and granzyme-B (St Leger
and Hendricks, 2011).
Recent studies with HSV-1 suggest that infection of neurons
after axonal entry is inherently biased toward a latent infection
because when the HSV-1 virions enter axons, some critical tegu-
ment proteins are transported toward the cell body separately
from the capsid (Roizman and Sears, 1987). When neuronal
cell bodies are exposed directly to purified virions, the infection
is instead productive. This bias toward latency presumably
occurs because productive infection may require that both tegu-
ment proteins and capsids containing the viral genome arrive at
the nucleus at the same time (Hafezi et al., 2012; Kristie andRoiz-
man, 1988). Besides this long-distance trafficking, other factors
such as cytokine and IFN production also influence the outcome.
The cytokines produced after primary infection of epithelial cells
or the virion attachment to axonal receptors might induce an
antiviral state in neuronal soma before the genome reaches the
nucleus. Indeed, De Regge et al., using an in vitro two-chamber
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ganglion neurons with IFN-a before HSV-1 or PRV infection is
sufficient to suppress lytic gene expression and induce a quies-
cent infection (De Regge et al., 2010).
A hallmark of alpha herpesvirus latency is the expression of a
latency-associated transcript (LAT) and several microRNAs
(miRNAs) (Farrell et al., 1991; Umbach et al., 2008). Although
the exact role of the LAT transcripts is still not well understood,
there is evidence that these noncoding RNAs are involved in
blocking apoptosis of the infected neuron and in the control of
reactivation from latency (reviewed in Proenc¸a et al., 2011).
Besides LAT, HSV-1miRNAs target the key regulators of the viral
lytic cycle (i.e., ICP0) to control and stabilize latency. Remark-
ably, for VZV, six different transcripts and proteins are produced
during latency. Interestingly, one of the most abundant proteins,
ORF63, is predominantly cytoplasmic during latency but local-
izes mostly in the nucleus during lytic infection (Cohen, 2007).
Nevertheless, almost 90%of the viral genome remains transcrip-
tionally silent during latent HSV-1, HSV-2, or PRV infection, and,
importantly, the infected neuron is not recognized or eliminated
by the immune system.
Such long-term maintenance of a silenced viral genome in a
state that can be reactivated requires precise control and a
high threshold for reactivation. Stress responses, including nutri-
tional, hormonal, and environmental, can reactivate a latent
genome. Strikingly, although reactivation can recur throughout
the life of the host, it seems to have little adverse effect on
PNS function. This is, in part, because few latently infected neu-
rons undergo reactivation: in vivo animal experiments show that
only one to three neurons, among thousands of latently infected
cells in the trigeminal ganglion, display signs of reactivation in a
single recurrence (Sawtell and Thompson, 1992).
Furthermore, neurons have evolved to inherently avoid cell
death, and viruses that persist in neurons have also adapted to
prevent the death of their host cells. These neuronal and viral
prosurvival strategies clearly allow neurons to survive during a
latent herpesvirus infection, but it may be that these same stra-
tegies promote neuronal survival during reactivation as well. It
appears that a fine balance exists between the immune system
of a naturally immunized host and the virus replication machin-
ery, limiting virus replication and subsequent axon-to-cell spread
of the progeny even during reactivation (Kobiler et al., 2010; Tay-
lor et al., 2012). Indeed, it appears that neurons can tolerate not
only high viral genome inputs but also abundant viral gene
expression, which possibly is controlled by the suppressing ac-
tion of nearby CD8+ T cells (St Leger and Hendricks, 2011).
Furthermore, autophagy is a neuronal prosurvival strategy to
block several neurotropic virus infections (i.e., Sindbis virus
[SINV], HCMV, HSV-1) (Chaumorcel et al., 2008; Orvedahl
et al., 2007, 2010). The autophagy machinery normally is used
by cells to engulf cytosolic material in a double-membrane
vesicle to be degraded by the lysosomes. HSV-1 encodes pro-
teins that modulate autophagy in a neuron-specific manner.
For example, autophagy is activated in response to HSV-1 infec-
tion through interferon-induced protein kinase R (PKR), which
induces an antiviral signaling cascade in response to viral dsRNA
(Tallo´czy et al., 2002). The HSV-1 protein ICP34.5 interferes with
this pathway by binding to and inactivating Beclin-1, a host pro-
tein responsible for the recruitment of other autophagy proteins(Orvedahl et al., 2007). This interaction has little effect or advan-
tage in nonneuronal cells, but it promotes HSV-1 persistence in
neurons and also pathogenesis if the infection spreads to the
CNS (Yordy et al., 2012).
After reactivation, it is not clear whether progeny herpesvirus
virions are transported toward the CNS and, if so, what prevents
devastating CNS infection and pathogenesis in most immune-
competent individuals. A recent elegant study revealed the
importance of neuronal intrinsic immunity in the control of
HSV-1 spread in the NS. Children with genetic defects in the
antiviral TLR3-interferon pathway have a higher risk of herpes
simplex encephalitis (HSE) during primary infection with HSV-
1. Using pluripotent stem cells from susceptible children, the
authors showed that a TLR3-dependent intrinsic immune
response in neurons is crucial to restrict HSV-1 spread in the
NS (Lafaille et al., 2012). It is likely that the lack of this defense
system in neurons prevents the establishment of latency in the
peripheral ganglia, promoting further viral spread into the brain.
Once in the brain, where HSV-1 replication is normally tightly
restricted, TLR-3 deficient neurons may continue to support
virus replication leading to HSE.
The herpesvirus latency-reactivation cycle is understood in
principle, but important details are lacking. Small-animal models
(i.e., mouse peripheral infection and rabbit eye models to study
HSV-1 and guinea pig model for HSV-2 latency) have been quite
useful, but they do not recapitulate all the nuances of latency in
humans (Wagner and Bloom, 1997; Wilson and Mohr, 2012).
However, latency and reactivation have been addressed with
PNS neurons cultured in vitro, and these studies have provided
some mechanistic understanding of these phenomena (Camar-
ena et al., 2010; Wilcox et al., 1990). HSV-1 latency is proposed
to be maintained by the continuous binding of NGF to the TrKA
receptor tyrosine kinase (RTK) and activation of phosphatidylino-
sitol 3-kinase (PI3K)-Akt signaling pathway (Camarena et al.,
2010; Wilcox et al., 1990). Recently, Kobayashi et al. further
showed that the key target of PI3K-Akt signaling is mTORC1 in
axons (Kobayashi et al., 2012). The mTOR system regulates
the translational repressor eIF4E-binding protein (4E-BP), which
influences the state of latent viral genomes in the neuronal
nucleus. Although the cellular effectors of this pathway that
suppress the viral lytic gene expression are still unknown, any
interference with this signaling cascade (e.g., NGF depletion, in-
hibition of mTOR activity, or hypoxia) breaks latency control and
promotes reactivation. It appears that a variety of physiological
stimuli originating in the periphery are integrated in the local
mTOR system in axons and relayed to the cell body. This local
monitoring in axons and long distance signaling to the cell
body could alarm and protect neuronal cell bodies but at the
same time might be repurposed for the replication of opportu-
nistic viruses that invade the nervous system (Figure 4).
What Controls Invasion of the Nervous System:
A Herpesvirus Perspective
Alpha herpesvirus infection of immune-competent hosts
presents an apparent two-part paradox: First, during primary
infection, the infection passes with high efficiency from epithelial
surfaces to the nerve terminals and on to the soma of PNS
ganglia neurons. Indeed, it is difficult to block primary PNS inva-
sion once epithelial cells are infected. Second, once in the PNS,Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc. 389
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animal models and mutant virus infections that a complex inter-
play exists between the host immune system and the NS adapt-
ed viral replication strategy. For instance, virulent PRV infection
of the skin induces a violent, inflamed peripheral pruritus with
almost no further spread to the brain in mice (Brittle et al.,
2004). By contrast, the attenuated mutant strain PRV Bartha,
which replicates as well as wild-type virus, produces almost no
tissue damage and peripheral inflammation yet is massively neu-
roinvasive (Brittle et al., 2004). This property makes PRV Bartha
an excellent neural tracer (Brittle et al., 2004).
What regulates controlled alpha herpesvirus spread in the NS,
and how does the infection proceed differently in neurons, non-
neuronal cells, PNS neurons, and CNS neurons? The answer
may lie within the specialized signaling and gene expression pat-
terns that maintain highly polarized morphology and function of
neurons. Such a differentiated system calls for a long-distance
communication between the axon terminals that are in contact
with epithelial or muscle cells and the cell bodies in the ganglia.
This axon-to-cell-body communication must be finely tuned, so
that cell bodies are well informed about distant events near axon
terminals but at the same time should not overreact. It is note-
worthy that PNS neurons produce little type I IFN after HSV-1
infection (Leib et al., 1999; Szpara et al., 2010). However, when
herpes virions invade epithelial cells, prior to infecting nerve
terminals, these infected cells produce a variety of inflammatory
and antiviral cytokines, including type I IFN. Such potent
signaling molecules are likely to have an effect on local axon
function and subsequent viral invasion of PNS neurons (Cun-
ningham and Mikloska, 2001). Indeed, previous work on human
dorsal root ganglion neurons in a chambered culture system
showed that IFN-a and IFN-g, added to the epidermal cell
compartment, after axonal transmission of HSV-1 infection,
inhibit infection and spread (Mikloska and Cunningham, 2001).
Certainly, information about events at nerve termini (i.e., dam-
age, inflammation, and infection) must be transmitted to the
distant neuronal cell bodies to produce an appropriate response
at the site of axonal insult. Because some axons can be centime-
ters to meters long, efficient and rapid transmission presents a
potential problem for homeostasis of the neuron. How this long
distance communication is accomplished remains a funda-
mental problem in neuroscience and in virology. New findings
suggest that new protein synthesis in axons upon environmental
stimuli and subsequent transport of local signaling molecules to
the nuclei might serve this function. Indeed a subset of mRNAs
and the complete protein synthesis machinery are localized to
axons in uninfected neurons, far away from the cell body (Vuppa-
lanchi et al., 2009). Local translation in axons, not in the distant
cell body, regulates growth cone navigation and integrity during
development and regeneration, and retrograde communication
with the cell body in adult neurons and plays a key role in axonal
damage signaling (Jung et al., 2012).
We have found that local events involving axonal protein syn-
thesis in or near the initially infected axon termini facilitate neural
invasion and spread (Koyuncu et al., 2013). Our results also sug-
gest that virus infection stimulates an axonal response similar to
injury signaling and that these damage or danger signals induced
by initial axonal infection and subsequent inflammatory events at
the site of primary infection affect axonal transport of viral parti-390 Cell Host & Microbe 13, April 17, 2013 ª2013 Elsevier Inc.cles to the neuronal nuclei. Interestingly, retrograde transport of
poliovirus to the CNS in mice is inefficient unless there is muscle
damage at the site of infection (Lancaster and Pfeiffer, 2010). For
PRV, we and others have seen almost the opposite: tissue dam-
age blocks neural invasion (Duale et al., 2009; Koyuncu et al.,
2013). Perhaps these local events in the PNS ganglia or near
the infected axons contribute to determination of lytic versus
latent infection states and control of further neuroinvasion.
It is still a mystery why spread of alpha herpesviruses to the
CNS after the initial peripheral infection or after reactivation
from latency is rare. There is no evidence that the block is at
the cellular and molecular level of axonal transport to the CNS
neurons. Perhaps the limitation is in the replication of virus in
CNS neurons. Like PNS neurons, these neurons may be less
permissive to lytic herpesvirus infection. CNS and PNS neurons
may both have specialized intrinsic immune responses that pro-
mote abortive infections and long-term maintenance of latency.
The suggestion that herpesvirus particles or genomes are pre-
sent in the brain of latently infected individuals draws attention
to possible correlation between herpesvirus infection and neuro-
pathologies like Alzheimer’s disease (Hill et al., 2005). Such cor-
relations remain difficult to study due to the lack of appropriate
experimental models.
Future Perspectives
The interaction of viruses with their hosts is noteworthy in many
ways. Studying the complex interplay between these tiny intra-
cellular entities and the infected cell in a culture dish has taught
us many valuable lessons in cell biology. However this interac-
tion between virus and host in vivo is even more complicated
by the hierarchical organization of cells, tissues, and systems.
This complexity, while providing layers of protection against
microbial invasions, also requires strictly regulated communica-
tion among cells and tissues to produce the appropriate protec-
tive response. If this combined reaction to viral attack is not
sufficient, balanced, and controlled, severe pathology is likely.
It is striking that there is no prototypical virus that spreads to
the CNS. Viruses with RNA or DNA genomes and enveloped or
naked virions, members of diverse virus families, all can spread
into the CNS under the right conditions. In general, even viruses
capable of infecting a variety of cell types tend to spread from
one tissue to another until they reach a barrier. If the infection
is not contained locally (due to inefficient intrinsic and innate
immune reaction), it can spread to vital organs, causing severe
pathologies. Damage to cells can result from viral replication or
by the action of the activated immune system. Virus spread to
CNS can be deadly, not only because infected neurons may
die, but also because of the immune-mediated inflammation in
the brain. We now recognize that we are constantly infected
and colonized with numerous microorganisms, some of which
can affect spread and pathogenesis of invading microbes (the
microbiome). This complex interaction of host and microbes
was not recognized and was routinely neglected in in vitro and
in vivo experimental models. However, recent pioneering work
(Kuss et al., 2011; Matullo et al., 2011) suggests methods and
models of how to approach these complex and multifactorial
biological problems.
Historically, research on PNS-adapted alpha herpesviruses,
zoonotic RABV, and enteric poliovirus taught us much of what
Cell Host & Microbe
Reviewwe know about viral spread in the NS. Developing techniques
such as live-cell and intravital imaging together with neuron
culturing methods (in chambers or microfluidic devices, and co-
cultures with other cell types) accompanied by the ability to
construct recombinant viruses now allow researchers to study
some of the fundamental characteristics of virus replication
and spread within and between neurons. These approaches
will enable new mechanistic understanding of how neurotropic
viruses gain access to and spread in theNS. In vitro culture of hu-
man neuronal/pluripotent stem cells, and closer-to-natural-host
models such as ‘‘humanized mice’’ carrying human-specific
genes, cells, or tissues will reveal host-specific aspects of lytic
or latent infections caused by human viruses. Novel techniques,
such as deep sequencing of viral nucleic acid from clinical
samples or single-molecule sequencing will facilitate identifica-
tion of more neurovirulent and/or neuroinvasive virus mutants
and will provide a genetic view of host barriers and viral bypass
mechanisms. Screening of diseased tissues by these techniques
will enable the detection of minute quantities of viral genomic
material, possibly revealing more roles for viruses in a variety
of neuropathologies even if we cannot propagate them in the
laboratory.
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